Process View
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "extrinsic apoptotic signaling pathway in absence of ligand"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BCL2 | B-cell CLL/lymphoma 2 | 1.000 | ||
| BCL2L1 | BCL2-like 1 | 0.999 | Human Mouse | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.991 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.985 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.971 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.970 | Mouse | |
| BAX | BCL2-associated X protein | 0.965 | Human Mouse | |
| HSPA1B | heat shock 70kDa protein 1B | 0.931 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.870 | Human | |
| BAD | BCL2-associated agonist of cell death | 0.834 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.832 | Mouse | |
| BID | BH3 interacting domain death agonist | 0.774 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.621 | Mouse | |
| EGFR | epidermal growth factor receptor | 0.609 | Human | |
| IL1R1 | interleukin 1 receptor, type I | 0.589 | ||
| B2M | beta-2-microglobulin | 0.514 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.501 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.475 | Human | |
| PML | promyelocytic leukemia | 0.437 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.406 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.391 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.376 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.373 | Mouse | |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.373 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.373 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.342 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.336 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.276 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.240 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.231 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.226 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.201 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.197 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.188 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.182 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.168 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.139 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.135 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.132 | ||
| IL1B | interleukin 1, beta | 0.127 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.126 | ||
| IL4R | interleukin 4 receptor | 0.125 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.122 | Mouse | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.120 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.118 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.115 | Mouse | |
| MAPK14 | mitogen-activated protein kinase 14 | 0.113 | ||
| IL8 | interleukin 8 | 0.113 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.110 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.102 | Human | |
| IL1R2 | interleukin 1 receptor, type II | 0.102 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.101 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.095 | ||
| TNF | tumor necrosis factor | 0.093 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.085 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.083 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.081 | Human | |
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.080 | Rat | |
| DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 0.077 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.076 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.074 | ||
| DAXX | death-domain associated protein | 0.073 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.073 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.072 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.062 | Human | |
| HSPB1 | heat shock 27kDa protein 1 | 0.060 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.059 | ||
| BCL2A1 | BCL2-related protein A1 | 0.058 | Human | |
| HSPB8 | heat shock 22kDa protein 8 | 0.055 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.055 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.055 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.053 | Human | |
| THBS1 | thrombospondin 1 | 0.053 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.052 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.049 | ||
| PF4 | platelet factor 4 | 0.048 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.047 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.046 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.046 | ||
| JUP | junction plakoglobin | 0.044 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.043 | ||
| STIP1 | stress-induced-phosphoprotein 1 | 0.042 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.041 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.041 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.041 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.039 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.039 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.037 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.037 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.037 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.036 | ||
| EIF4G3 | eukaryotic translation initiation factor 4 gamma, 3 | 0.036 | ||
| AXIN1 | axin 1 | 0.036 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.035 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.035 | ||
| BANP | BTG3 associated nuclear protein | 0.034 | ||
| IFI27 | interferon, alpha-inducible protein 27 | 0.033 | Human | |
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.033 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.031 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.031 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.031 | ||
| KLF13 | Kruppel-like factor 13 | 0.029 | ||
| ASRGL1 | asparaginase like 1 | 0.028 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.027 | ||
| BBC3 | BCL2 binding component 3 | 0.027 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.026 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.026 | Human | |
| KAT2B | K(lysine) acetyltransferase 2B | 0.026 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.025 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.025 | ||
| FOXO1 | forkhead box O1 | 0.024 | ||
| APP | amyloid beta (A4) precursor protein | 0.024 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.024 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.023 | ||
| APC | adenomatous polyposis coli | 0.023 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.023 | ||
| IFNG | interferon, gamma | 0.023 | ||
| RNF144B | ring finger protein 144B | 0.023 | ||
| BAG1 | BCL2-associated athanogene | 0.022 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.022 | Human | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.022 | ||
| STK11 | serine/threonine kinase 11 | 0.021 | ||
| CTTNBP2NL | CTTNBP2 N-terminal like | 0.021 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.021 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.021 | ||
| CD320 | CD320 molecule | 0.021 | ||
| MAGEA2 | melanoma antigen family A, 2 | 0.020 | ||
| IL1A | interleukin 1, alpha | 0.020 | Human Mouse | |
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.020 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.020 | Human | |
| ATM | ataxia telangiectasia mutated | 0.019 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.019 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.018 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.018 | ||
| UBD | ubiquitin D | 0.018 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.018 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.018 | ||
| INSR | insulin receptor | 0.018 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.018 | Mouse | |
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.018 | ||
| PF4V1 | platelet factor 4 variant 1 | 0.018 | Human | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.018 | ||
| IFI44L | interferon-induced protein 44-like | 0.018 | ||
| LAMP2 | lysosomal-associated membrane protein 2 | 0.017 | ||
| TBX5 | T-box 5 | 0.017 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.017 | ||
| IL7R | interleukin 7 receptor | 0.017 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.017 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.017 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.016 | ||
| MAGEH1 | melanoma antigen family H, 1 | 0.016 | ||
| IL11 | interleukin 11 | 0.016 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.016 | ||
| HBB | hemoglobin, beta | 0.016 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.016 | ||
| SQSTM1 | sequestosome 1 | 0.016 | ||
| SMG6 | Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) | 0.016 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.016 | ||
| DLG3 | discs, large homolog 3 (Drosophila) | 0.015 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.015 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.015 | ||
| PSEN1 | presenilin 1 | 0.015 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.015 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.015 | Human | |
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.014 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.014 | ||
| BCL2L2 | BCL2-like 2 | 0.014 | Human | |
| PI3 | peptidase inhibitor 3, skin-derived | 0.014 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.014 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.013 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.013 | ||
| CTBP1 | C-terminal binding protein 1 | 0.013 | ||
| PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.013 | ||
| FST | follistatin | 0.013 | ||
| TRO | trophinin | 0.013 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.013 | ||
| APOL1 | apolipoprotein L, 1 | 0.013 | ||
| CRYAB | crystallin, alpha B | 0.012 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.012 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.012 | Human | |
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.012 | ||
| STRADA | STE20-related kinase adaptor alpha | 0.011 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.011 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.011 | ||
| KIAA1967 | KIAA1967 | 0.011 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
| EFNA1 | ephrin-A1 | 0.011 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.011 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.011 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.011 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.011 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.011 | ||
| LDLR | low density lipoprotein receptor | 0.011 | ||
| CD83 | CD83 molecule | 0.011 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.011 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.011 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.011 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.011 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.011 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.011 | ||
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.011 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.010 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.010 | ||
| NRG1 | neuregulin 1 | 0.010 | ||
| SFN | stratifin | 0.010 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.010 | ||
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 0.010 | ||
| CD274 | CD274 molecule | 0.010 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.010 |